Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor 8 (FGF8) is a secreted signaling protein belonging to the fibroblast growth factor family, with vital roles in embryonic development, organogenesis, cell proliferation, differentiation, and tissue repair[1][3][7]. FGF8 is particularly crucial for neural and limb development, midbrain-hindbrain patterning, and the emergence of gonadotropin-releasing hormone neurons, and it signals through fibroblast growth factor receptors (primarily FGFR1) to mediate its effects[1][3][7]. Abnormal FGF8 activity or mutations are linked to congenital disorders such as Kallmann syndrome and various cancers, making it a potential, albeit challenging, therapeutic target in oncology, skeletal disease, and endocrinology[1][3][5].
FGFR inhibitors: block FGF8-induced receptor activation and downstream signaling. Experimental antibodies or ligand traps: block FGF8 binding to its receptor[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast growth factor 8 (FGF8).